These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25276255)

  • 1. Serum anti-glycan antibodies in paediatric-onset Crohn's disease: association with disease phenotype and diagnostic accuracy.
    Sładek M; Wasilewska A; Swiat A; Cmiel A
    Prz Gastroenterol; 2014; 9(4):232-41. PubMed ID: 25276255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Correlation between New Serological Markers and Disease Phenotype and Activation in Inflammatory Bowel Disease.
    Yorulmaz E; Adalı G; Yorulmaz H; Taşan G; Gürses S; Ayaş MR; Tuncer İ
    Middle East J Dig Dis; 2022 Jul; 14(3):294-303. PubMed ID: 36619271
    [No Abstract]   [Full Text] [Related]  

  • 4. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of serological biomarkers in patients with Crohn's disease: A case-control study.
    Yao F; Fan Y; Lv B; Ji C; Xu L
    Medicine (Baltimore); 2018 Aug; 97(32):e11772. PubMed ID: 30095633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior.
    Rieder F; Schleder S; Wolf A; Dirmeier A; Strauch U; Obermeier F; Lopez R; Spector L; Fire E; Yarden J; Rogler G; Dotan N; Klebl F
    Inflamm Bowel Dis; 2010 Feb; 16(2):263-74. PubMed ID: 19653286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of anti-glycan antibodies in pediatric Crohn's disease in comparison with an adult cohort.
    Rieder F; Hahn P; Finsterhoelzl L; Schleder S; Wolf A; Dirmeier A; Lopez R; Shen B; Rogler G; Klebl F; Lang T
    Inflamm Bowel Dis; 2012 Jul; 18(7):1221-31. PubMed ID: 22147427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease.
    Goren I; Yahav L; Tulchinsky H; Dotan I
    Inflamm Bowel Dis; 2015 Oct; 21(10):2289-95. PubMed ID: 26197448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New serologic markers for inflammatory bowel disease diagnosis.
    Dotan I
    Dig Dis; 2010; 28(3):418-23. PubMed ID: 20926866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis.
    Rieder F; Lopez R; Franke A; Wolf A; Schleder S; Dirmeier A; Schirbel A; Rosenstiel P; Dotan N; Schreiber S; Rogler G; Klebl F
    PLoS One; 2011 May; 6(5):e18172. PubMed ID: 21573154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort.
    Malickova K; Lakatos PL; Bortlik M; Komarek V; Janatkova I; Lukas M
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):144-50. PubMed ID: 19927001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.
    Werner L; Sturm A; Roggenbuck D; Yahav L; Zion T; Meirowithz E; Ofer A; Guzner-Gur H; Tulchinsky H; Dotan I
    J Crohns Colitis; 2013 Dec; 7(11):e522-32. PubMed ID: 23639628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease serology in Asia and the West.
    Prideaux L; Kamm MA; De Cruz P; van Langenberg DR; Ng SC; Dotan I
    World J Gastroenterol; 2013 Oct; 19(37):6207-13. PubMed ID: 24115818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological markers of inflammatory bowel disease.
    Kuna AT
    Biochem Med (Zagreb); 2013; 23(1):28-42. PubMed ID: 23457764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of anti-glycan antibodies in patients with cystic fibrosis.
    Hirche TO; Stein J; Hirche H; Hausmann J; Wagner TO; Behrens F; Schröder O
    Eur J Med Res; 2011 Sep; 16(9):385-90. PubMed ID: 22024437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of serum antibodies in differentiating inflammatory bowel disease, predicting disease activity and disease course in the newly diagnosed patient.
    Smids C; Horjus Talabur Horje CS; Groenen MJM; van Koolwijk EHM; Wahab PJ; van Lochem EG
    Scand J Gastroenterol; 2017 Oct; 52(10):1104-1112. PubMed ID: 28661185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel anti-carbohydrate autoantibodies in patients with inflammatory bowel disease: are they useful for clinical practice?
    Malickova K; Lukas M; Donoval R; Sandova P; Janatkova I
    Clin Lab; 2006; 52(11-12):631-8. PubMed ID: 17175895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiglycan antibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Drygiannakis D; Tsirogianni A; Oustamanolakis P; Karmiris K; Papamichael K; Mantzaris GJ; Kouroumalis EA
    Dig Dis Sci; 2011 Mar; 56(3):845-52. PubMed ID: 20632100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour.
    Ferrante M; Henckaerts L; Joossens M; Pierik M; Joossens S; Dotan N; Norman GL; Altstock RT; Van Steen K; Rutgeerts P; Van Assche G; Vermeire S
    Gut; 2007 Oct; 56(10):1394-403. PubMed ID: 17456509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.